Diagnostic Kit for CBV-IgG Antibody (ELISA)

Product Description:

The Diagnostic Kit for IgM Antibody to CBV (ELISA) operates based on the principle of Enzyme-Linked Immunosorbent Assay (ELISA). Here's a breakdown of the principle:

1. **Coating**: The wells of a microplate are coated with antigens specific to Coxsackievirus B (CBV). These antigens are purified forms of proteins or peptides derived from CBV that are known to elicit an immune response, particularly IgM antibodies.

2. **Sample Addition**: Patient serum or plasma samples, which potentially contain IgM antibodies against CBV, are added to the wells.

3. **Antibody Binding**: If IgM antibodies specific to CBV are present in the sample, they will bind to the coated antigens on the well surface.

4. **Washing**: After an incubation period allowing antibodies to bind, the wells are washed to remove unbound substances such as unreacted antibodies.

5. **Enzyme Conjugation**: An enzyme-linked secondary antibody specific to human IgM is added. This secondary antibody is conjugated to an enzyme such as horseradish peroxidase (HRP) or alkaline phosphatase (AP).

6. **Substrate Addition**: A substrate solution specific to the enzyme is added. This substrate undergoes a reaction catalyzed by the enzyme, resulting in a color change (e.g., from colorless to colored) or a luminescent signal.

7. **Signal Detection**: The intensity of the color or luminescent signal is proportional to the amount of IgM antibodies bound to the wells, which in turn reflects the presence and concentration of IgM antibodies specific to CBV in the patient's sample.

8. **Quantification**: The optical density (OD) or luminescence is measured using a spectrophotometer or a luminometer, respectively. This measurement allows for the quantification of IgM antibodies present in the sample.

In summary, the ELISA principle used in the Diagnostic Kit for IgM Antibody to CBV detects and quantifies IgM antibodies against Coxsackievirus B by utilizing antigen-antibody binding and enzyme-linked detection systems, providing a reliable method for diagnosing CBV infections.

Features:

• Product Name: Diagnostic Kit for CBV-IgG Antibody (ELISA)
• Sensitivity: High
• Country of Origin: China
• Storage Temperature: 2-8°C
• Sample Type: Serum, Plasma
• Format: Kit
• Product Description:Immunoassay Test Kit for Serological Detection

Applications:

Diagnostic kits for IgM antibodies to Coxsackievirus B (CBV) using ELISA have several applications in clinical and epidemiological settings:

1. **Clinical Diagnosis**: These kits are primarily used in clinical laboratories to aid in the diagnosis of recent or acute Coxsackievirus B infections. Detection of IgM antibodies indicates recent exposure to the virus, helping clinicians confirm a diagnosis in patients presenting with compatible symptoms.

2. **Epidemiological Surveillance**: Health authorities and researchers use these kits for surveillance purposes to monitor the prevalence and incidence of Coxsackievirus B infections within a population or geographic area. This helps in understanding the epidemiology of the virus and identifying outbreaks.

3. **Screening and Monitoring**: In outbreak situations or in high-risk populations (such as newborns, immunocompromised individuals, and pregnant women), these kits can be used for screening to detect early infections or monitor the immune response over time.

4. **Research and Development**: These kits are also valuable in research settings to study the prevalence, transmission dynamics, and immune response patterns associated with Coxsackievirus B infections. They contribute to the development of new diagnostic methods and therapeutic strategies.

5. **Public Health Interventions**: Rapid and accurate detection of IgM antibodies using these kits can guide public health interventions, such as implementing control measures to prevent further spread of the virus and informing vaccination strategies where available.

Overall, the application of Diagnostic Kits for IgM Antibody to CBV (ELISA) plays a crucial role in both clinical diagnostics and public health efforts related to Coxsackievirus B infections, providing essential tools for timely diagnosis, surveillance, and management of the disease.

Customization:

The packaging details are in carton and the delivery time is 7-15 days. The payment terms are TT 100% payment and the supply ability is 100,000. This Enzyme-Linked Immunosorbent Assay Test Kit has a country of origin of China and should be stored at a temperature range of 2-8°C.